Gsk872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of rip1/rip3/mlkl pathway in glutamate-induced retinal excitotoxic model of glaucoma

HIGHLIGHTS

  • who: Mengyuan Liu from the Eye Center of Xiangya Hospital, Central South University, Changsha, Hunan, People`s Republic of China have published the research: GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1/RIP3/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma, in the Journal: (JOURNAL)
  • what: This study aimed to investigate the potential role of necroptosis in glutamate-induced RGCs death and the underlying mechanisms, as well as the neuroprotective effects of Nec-1 and GSK872 on glutamate excitotoxicity in RGCs. Combined with the results presented previously . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?